Robert J. Coury
Robert J. Coury was elected to the Board of Directors in 2002, serving as Vice Chairman until being named Chairman in 2009. In addition, Coury is Mylan's Chief Executive Officer, a position he has held since 2002. During his tenure, the company has been transformed from the third largest generics company in the United States to the third largest generics and specialty pharmaceutical company in the world with the acquisitions of Matrix Laboratories and the global generics business of Merck KGaA. Prior to joining Mylan, Coury was the principal of Coury Consulting L.P., a corporate strategy advisory firm he formed in 1989 in Pittsburgh, Pennsylvania.
Rodney L. Piatt
Rodney L. Piatt was elected to the Board of Directors of Mylan in 2004, currently serving as Vice Chairman. Mr. Piatt brings to Mylan extensive experience as an auditor and successful business leader and is a member of the Mylan Audit, Finance, Compensation and Governance and Nominating Committees.
Wendy Cameron
Wendy Cameron is director and co-owner of Cam Land LLC, a harness racing business in Washington, Pennsylvania, and was appointed to the Board of Directors of Mylan in 2002. Ms. Cameron is a member of the Mylan Compensation and Governance and Nominating Committees.
Neil Dimick
Neil Dimick was elected to the Mylan Board of Directors in October 2005. He chairs Mylan's Finance Committee and is a member of its Audit Committee.
Douglas J. Leech CPA
Douglas J. Leech was elected to the board of directors of Mylan in 2000. Leech is the chair of the Mylan Audit Committee and a member of the Compliance, Finance, and Corporate Governance and Nominating Committees.
Joseph C. Maroon M.D.
Joseph C. Maroon, M.D. was appointed to the Board of Directors of Mylan in 2003. He is also a member of Mylan's Compensation Committee.
Mark W. Parrish
Mark W. Parrish was elected to the Board of Directors of Mylan in 2009.
Parrish is the chairman and CEO of Trident USA Health Services, the nation's largest provider of mobile x-ray and laboratory services to the long-term care industry. He also is president of the International Federation of Pharmaceutical Wholesalers, an association comprising the largest pharmaceutical wholesalers and pharmaceutical supply chain service companies in the world. He also serves as a senior adviser to Frazier Healthcare Ventures, a health care oriented growth equity firm, and as a director of Biovail Corporation.
Previously, Parrish was CEO of Healthcare Supply Chain Services for Cardinal Health, an $91 billion global manufacturer and distributor of medical and surgical supplies and technologies. Parrish also held a variety of other leadership roles at Cardinal Health, including group president, Pharmaceutical Supply Chain Services; president and chief operating officer, Pharmaceutical Supply Chain Services; chairman and CEO, Pharmaceutical Distribution and Provider Services; executive vice president and group president, Pharmaceutical Distribution; and president, Medicine Shoppe.
Prior to joining Cardinal Health, Parrish held positions in health care distribution companies in the pharmaceutical and medical surgical product sectors.
Parrish earned a Bachelor of Arts degree from the University of California, Berkeley.
C.B. Todd
C.B. Todd was elected to the Board of Directors of Mylan in 1993. He is also a member of the Mylan Compliance Committee.
Randall L. Vanderveen
Randall "Pete" Vanderveen was elected to the Board of Directors of Mylan in 2002. He is a member of the Mylan Compliance Committee.| Legal and Copyright Disclaimer. | © Copyright 2010 Mylan Inc. All rights reserved. | Privacy Policy. |